Dr. Corrigan has served as our President and Chief Executive Officer since January 2010. Dr. Corrigan joined U.S.-based specialty pharmaceutical company Sepracor Inc. in 2003 and served as their Executive Vice President, Research and Development until December 2009. Prior to joining Sepracor, Dr. Corrigan spent 10 years with Pharmacia & Upjohn Inc., most recently as Group Vice President of Global Clinical Research and Experimental Medicine. Dr. Corrigan has been a member of the board of directors and the audit committee of Cubist Pharmaceuticals, Inc. since 2008. Prior to joining the pharmaceutical industry, Dr. Corrigan spent five years in academic research at the University of North Carolina School of Medicine focusing on psychoneuroendocrinology. Dr. Corrigan holds a B.A. and an M.D. from the University of Virginia and subsequently received specialty training in psychiatry at Maine Medical Center and Cornell University.
Mr. Renz joined us in September 2006 as Vice President, Finance and Treasurer and was appointed as our Senior Vice President, Chief Financial Officer and Treasurer in July 2009 and as our Executive Vice President as of March 2012. From August 2005 to September 2006, Mr. Renz was Director, Accounting and Financial Operations at EMD Serono. From 2002 to 2005, he was Senior Director, Global Accounting and Finance at Coley Pharmaceutical Group and has also held financial and accounting positions at ArQule, Inc., Millipore Corporation and Arthur Andersen LLP. Mr. Renz is a certified public accountant and holds a B.A. in economics/accounting from the College of the Holy Cross, a Masters in the Science of Taxation from Northeastern University and an M.B.A. from Suffolk University.